- Home
- SLRX vs ECPG Comparison
SLRX vs ECPG Comparison
Compare SLRX & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLRX | ECPG |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | 7350 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 1.2B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | SLRX | ECPG |
|---|---|---|
| Price | $0.65 | $55.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $59.50 |
| AVG Volume (30 Days) | ★ 309.0K | 241.2K |
| Earning Date | 11-14-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,560,869,000.00 |
| Revenue This Year | N/A | $32.56 |
| Revenue Next Year | N/A | $3.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.52 |
| 52 Week Low | $0.62 | $26.45 |
| 52 Week High | $108.00 | $56.67 |
Technical Indicators
Market Signals| Indicator | SLRX | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 24.90 | 62.08 |
| Support Level | $0.62 | $53.95 |
| Resistance Level | $0.72 | $55.72 |
| Average True Range (ATR) | 0.06 | 1.47 |
| MACD | 0.07 | -0.22 |
| Stochastic Oscillator | 0.00 | 56.03 |
Price Performance
Historical ComparisonAbout SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.